Location History:
- Farum, DK (2005 - 2016)
- Bagsværd, DK (2023)
Company Filing History:
Years Active: 2005-2025
Title: Celebrating the Innovations of Inventor Henning Thøgersen
Introduction: Henning Thøgersen, a dedicated inventor based in Bagsværd, Denmark, has made significant contributions to the field of therapeutic biomedicine. With a strong focus on the development of innovative treatments, his work has garnered attention and admiration in scientific communities.
Latest Patents: Thøgersen holds two notable patents, both related to novel derivatives of Interleukin-22 (IL-22). His latest patent details the invention of therapeutic derivatives of IL-22, specifically those comprising a fatty acid covalently attached to the IL-22 protein. This innovative approach aims to enhance the therapeutic potential of IL-22 in various medical applications.
Career Highlights: Henning currently works with Cytoki Pharma ApS, a company at the forefront of developing therapeutic solutions. His expertise and innovative mindset have contributed to the company's research and development efforts, particularly in creating effective treatments that leverage the properties of interleukins.
Collaborations: Throughout his career, Thøgersen has collaborated with esteemed colleagues, including Sebastian Beck Jørgensen and Thomas Hoeg-Jensen. These partnerships have enabled him to advance his research and contribute meaningfully to the field of biomedicine.
Conclusion: Henning Thøgersen's dedication to innovation and his impressive patent portfolio highlight his role as a key figure in the biopharmaceutical landscape. As he continues to explore the possibilities of IL-22 derivatives, his work promises to lead to significant advancements in therapeutic applications.